Hyperion DeFi (HYPD) AI Stock Analysis

• Market Cap: $54.50M
• Dividend Yield: N/A
• Average Volume (3M): 909.40K
• Price to Earnings (P/E): ―
• Beta (1Y): 3.25
• Revenue Growth: 41.50%
• EPS Growth: 52.13%
• Country: US
• Employees: 13
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -2.50
• Shares Outstanding: 5,694,659
• 10 Day Avg. Volume: 1,276,443
• 30 Day Avg. Volume: 909,400
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.69
• Enterprise Value/Revenue: 558.61
• Enterprise Value/Gross Profit: -10.24
• Enterprise Value/Ebitda: -0.96
• 1Y Price Target: $9.50
• Price Target Upside: -0.73% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 53 Neutral
• Price Target: $9.50 ▼(-0.73% Downside)

Eyenovia's overall stock score is primarily impacted by its weak financial performance, characterized by significant operational losses and a precarious balance sheet. Despite positive technical indicators suggesting a bullish trend, the poor valuation metrics further weigh down the score. The absence of earnings call data and corporate events limits additional insights.

Positive Factors

Revenue Growth

The company has demonstrated considerable revenue growth, indicating a strong demand for its services and potential for market expansion.

Innovative Business Model

The company's focus on decentralized finance and innovative financial solutions positions it well in the growing DeFi sector, offering unique value propositions.

Strategic Partnerships

Partnerships with liquidity providers and DeFi projects can drive user acquisition and revenue growth, strengthening the company's competitive position.

Negative Factors

Operational Losses

Persistent operational losses indicate inefficiencies and could hinder long-term sustainability, requiring strategic adjustments to achieve profitability.

Negative Profit Margins

Negative profit margins reflect high operational costs, which may limit the company's ability to reinvest in growth and innovation, affecting future competitiveness.

Precarious Balance Sheet

A precarious balance sheet with negative equity suggests financial instability, potentially limiting access to capital and increasing risk for investors.

Hyperion DeFi Business Overview & Revenue Model

Company Description

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.

How the Company Makes Money

Hyperion DeFi generates revenue through several key streams. Primarily, the company earns income by charging transaction fees on its platform for lending and borrowing services, which are typically a percentage of the total amount transacted. Additionally, it may earn a portion of the interest generated from loans as part of its lending protocols. Yield farming services also contribute to revenue, as the platform may take a fee from users who stake their assets for liquidity provisioning. Significant partnerships with liquidity providers and other DeFi-related projects can enhance earnings through shared revenue models and increased user acquisition. Furthermore, Hyperion DeFi may explore tokenomics strategies, such as issuing its own governance tokens, to create additional revenue through sales or staking mechanisms.

Hyperion DeFi Financial Statement Overview

Summary

Eyenovia is facing significant financial challenges with high operational losses, negative profitability margins, and a precarious balance sheet. The negative equity and insufficient cash flow generation further highlight the financial instability despite revenue growth.

Income Statement

Eyenovia has shown considerable revenue growth from 2023 to 2024 but continues to face significant losses. The gross profit margin remains negative, and the net profit margin is significantly low due to high operational costs and expenses. EBIT and EBITDA margins are also deeply negative, indicating operational inefficiencies.

Balance Sheet

The company's financial leverage is concerning, with a negative stockholders' equity indicating potential financial instability. The debt-to-equity ratio cannot be calculated due to negative equity, and the equity ratio is also negative, highlighting a risky financial structure.

Cash Flow

Eyenovia's cash flow remains negative, with decreasing free cash flow over the years. The operating cash flow to net income ratio is negative, suggesting inefficiencies in converting revenue into cash. Free cash flow to net income is also negative, indicating financial strain.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	57.34K	3.79K	0.00	14.00M	2.00M
Gross Profit	-3.87M	-12.22K	0.00	12.40M	1.20M
EBITDA	-46.21M	-24.11M	-26.32M	-12.17M	-19.66M
Net Income	-49.82M	-27.26M	-28.01M	-12.78M	-19.69M
Balance Sheet
Total Assets	3.67M	28.78M	31.04M	31.66M	33.91M
Cash, Cash Equivalents and Short-Term Investments	2.12M	14.85M	22.86M	19.46M	28.37M
Total Debt	11.24M	16.08M	10.12M	7.15M	463.35K
Total Liabilities	16.76M	19.78M	13.80M	11.19M	18.60M
Stockholders Equity	-13.10M	9.00M	17.23M	20.47M	15.30M
Cash Flow
Free Cash Flow	-30.28M	-27.81M	-25.98M	-22.49M	-6.65M
Operating Cash Flow	-30.12M	-23.84M	-25.11M	-20.87M	-6.38M
Investing Cash Flow	-161.48K	-3.97M	-874.75K	-1.62M	-261.26K
Financing Cash Flow	17.55M	19.79M	21.51M	21.46M	20.86M

Hyperion DeFi Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 9.57
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HYPD, the sentiment is Positive. The current price of 9.57 is above the 20-day moving average (MA) of 9.49, above the 50-day MA of 8.35, and above the 200-day MA of 5.20, indicating a bullish trend. The MACD of 0.60 indicates Positive momentum. The RSI at 50.96 is Neutral, neither overbought nor oversold. The STOCH value of 12.13 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HYPD.

Hyperion DeFi Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HYPD	53 Neutral	$54.50M	―	-228.74%	―	41.50%	52.13%
MTNB	45 Neutral	$9.67M	-0.49	―	―	―	24.30%
GLTO	29 Underperform	$5.84M	-0.34	―	―	―	44.00%
ENVB	24 Underperform	$1.97M	-0.06	―	―	―	80.53%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Hyperion DeFi Corporate Events

Hyperion DeFi Announces New Interim CEO and Board Expansion

On September 2, 2025, Hyperion DeFi, Inc. announced it had regained compliance with Nasdaq’s minimum equity requirement, following a previous notice of non-compliance. Additionally, the company experienced significant leadership changes, with CEO Michael Rowe resigning and Hyunsu Jung stepping in as Interim CEO. The board also expanded to include Happy Walters, a seasoned executive with expertise in sectors like telehealth and blockchain, who will serve on the Nominating and Governance Committee.

The most recent analyst rating on (HYPD) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Hyperion DeFi stock, see the HYPD Stock Forecast page.

Hyperion DeFi Expands Capital Structure Post-Annual Meeting

The 2025 Annual Meeting of Stockholders for Hyperion DeFi took place virtually on August 18, 2025, with a quorum of 51.40% of eligible shares present. Key decisions included the election of directors, ratification of CBIZ CPAs P.C. as the accounting firm, and approval of various amendments to the company’s charter and stock incentive plan. Notably, a proposal to allow stockholders to act by written consent did not pass, and an amendment to increase authorized shares was approved, indicating strategic moves to expand the company’s capital structure.

The most recent analyst rating on (HYPD) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Hyperion DeFi stock, see the HYPD Stock Forecast page.